Genmab Overview

State:Minnesota
Country:United States
Industry:Biotechnology and Drugs
Description:
Genmab is a recognized leader in the discovery and development of humanized monoclonal antibodies for the treatment of disease. The company's patented humanization technology platform is one of the most-widely validated antibody technologies in the industry. With seven marketed antibody products already licensed under its humanization patents and at least 40 additional humanized antibodies in clinical trials, Genmab believes the promise of its humanization technology is well on the way to becoming fully realized. The company leveraged its expertise in antibody humanization to become... (More)

Get Trial Access to OneSource

Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.

Disclaimer: While the OneSource Subscription Service maintains the freshest, most accurate data possible, this free site is refreshed on a periodic basis and may occasionally contain information that is not current. If you would like to alert us to a change, please email us, and we will take steps to make sure your update is included as soon as possible

Genmab Overview

Get Trial Access to OneSource

Business Information

Executive Profiles

Company Lists